Growing public scrutiny of the medical device industry and changes in political leadership in the US House suggest FDA oversight of devices could be elevated as a target for congressional oversight hearings in 2019, health-policy experts said Nov. 27.
“We have this pendulum of oversight of FDA regulation. It goes back and forth between more regulations and safety, and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?